Gilead Sciences
Top stories
Latest
- CAR T-Cell Therapy Market Forecasts Growth from $7.24B (2026) to $13.78B by 2031, Profiling Bristol-Myers Squibb, Gilead Sciences, Novartis & J&JGlobeNewswire — all · 2026-09-30 08:47 UTC · story
- Small Molecule Drug Discovery - Global Strategic Business Report Forecasts Growth from $61.5B (2024) to $100B by 2030, Profiling AstraZeneca, Gilead Sciences, Merck & PfizerGlobeNewswire — all · 2026-09-29 09:22 UTC · story
- Can Lenacapavir Power Gilead Sciences (GILD)'s Next Growth Phase?insidermonkey.com · 2026-09-29 00:43 UTC · story
- Critical Comparison: Gilead Sciences (NASDAQ:GILD) vs. Protalix BioTherapeutics (NYSE:PLX)dailypolitical.com · 2026-09-28 13:24 UTC · story